ArticleBMC neurology2026
Association of serum HMGB1 and TLR4 levels with early-onset post-stroke depression in type 2 diabetes: a prospective cohort study.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo explore the relationship between HMGB1 and TLR4 in early-onset post-stroke depression (PSD) among patients with type 2 diabetes mellitus (T2DM).
methodsA cohort of 100 patients diagnosed with T2DM and AIS, admitted to the First Affiliated Hospital of Henan Medical University from January to August 2024, was selected for this study. Based on criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, as well as scores from the Hamilton Depression Rating Scale-17 (HAMD-17), participants were categorized into either a non-PSD group or a PSD group. Logistic regression analysis was utilized to identify risk factors associated with early-onset PSD, while Receiver Operating Characteristic (ROC) curve analysis assessed the diagnostic performance of HMGB1 and TLR4 in predicting PSD among T2DM patients.
resultsUnivariate analysis revealed statistically significant differences in fasting blood glucose levels, serum TLR4 concentrations, and serum HMGB1 levels between both groups (p < 0.05). Logistic regression indicated that both TLR4 and HMGB1 serve as independent and significant risk factors for early-onset PSD in individuals with T2DM. The results from ROC curve analysis demonstrated that the area under the curve (AUC) values for HMGB1, TLR4, and their combined predictive capacity regarding early-onset PSD were 0.786 (95% CI: 0.676-0.897), 0.893 (95% CI: 0.802-0.984), and 0.902 (95% CI: 0.816-0.989).
conclusionElevated serum levels of TLR4 and HMGB1 may be correlated with early-onset PSD in patients suffering from T2DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.